Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis

Daniel A. Ermann; Victoria A. Vardell; Avyakta Kallam; Peter T. Silberstein; James O. Armitage

doi:10.1016/j.clml.2019.11.012

Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis

Daniel A. Ermann, Victoria A. Vardell, Avyakta Kallam, Peter T. Silberstein, James O. Armitage

Department of Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.

Original language	English (US)
Pages (from-to)	e174-e183
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/j.clml.2019.11.012
State	Published - Apr 2020

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.clml.2019.11.012

Cite this

Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma : A Survival Outcomes Analysis. / Ermann, Daniel A.; Vardell, Victoria A.; Kallam, Avyakta et al.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, No. 4, 04.2020, p. e174-e183.

Research output: Contribution to journal › Article › peer-review

@article{0f75694d60f942fc9253bd66c9febab3,

title = "Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis",

abstract = "Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.",

author = "Ermann, {Daniel A.} and Vardell, {Victoria A.} and Avyakta Kallam and Silberstein, {Peter T.} and Armitage, {James O.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = apr,

doi = "10.1016/j.clml.2019.11.012",

language = "English (US)",

volume = "20",

pages = "e174--e183",

journal = "Clinical Lymphoma",

issn = "2152-2669",

publisher = "Cancer Media Group",

number = "4",

}

TY - JOUR

T1 - Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma

T2 - A Survival Outcomes Analysis

AU - Ermann, Daniel A.

AU - Vardell, Victoria A.

AU - Kallam, Avyakta

AU - Silberstein, Peter T.

AU - Armitage, James O.

PY - 2020/4

Y1 - 2020/4

N2 - Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.

AB - Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.

UR - http://www.scopus.com/inward/record.url?scp=85079415708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079415708&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2019.11.012

DO - 10.1016/j.clml.2019.11.012

M3 - Article

C2 - 32067954

AN - SCOPUS:85079415708

VL - 20

SP - e174-e183

JO - Clinical Lymphoma

JF - Clinical Lymphoma

SN - 2152-2669

IS - 4

ER -

Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this